Health-Related Quality of Life (HRQoL) and Changes in Work Productivity Measures with Subcutaneous C1-Inhibitor [C1-INH(SC)] for the Prevention of Hereditary Angioedema (HAE) Attacks: Findings from the Compact Study

被引：1
|
作者：
Lumry, William [1 ]
Craig, Timothy J. [2 ]
Farkas, Henriette [3 ]
Feuersenger, Henrike [4 ,5 ]
机构：
[1] AARA Res Ctr, Dallas, TX USA
[2] Penn State Univ, Hershey Med Ctr, Hershey, PA USA
[3] Semmelweis Univ, Budapest, Hungary
[4] CSL Behring, Marburg, Germany
[5] CSL Behring, King Of Prussia, PA USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2017年 / 139卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2016.12.751
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
732
引用
收藏
页码：AB233 / AB233
页数：1
相关论文
共 50 条
  • [1] Switch from Intravenous C1-Inhibitor C1-INH(IV) to Subcutaneous C1-Inhibitor [C1 INH(SC)] for Routine Prevention of Hereditary Angioedema (HAE) Attacks: Subgroup Findings from the Compact Trial
    Craig, Timothy J.
    Baker, James W.
    Lumry, William R.
    Farkas, Henriette
    Feuersenger, Henrike
    Jacobs, Iris
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB230 - AB230
  • [2] Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema
    Lumry, William R.
    Craig, Timothy
    Zuraw, Bruce
    Longhurst, Hilary
    Baker, James
    Li, H. Henry
    Bernstein, Jonathan A.
    Anderson, John
    Riedl, Marc A.
    Manning, Michael E.
    Keith, Paul K.
    Levy, Donald S.
    Caballero, Teresa
    Banerji, Aleena
    Gower, Richard G.
    Farkas, Henriette
    Lawo, John-Philip
    Pragst, Ingo
    Machnig, Thomas
    Watson, Douglas J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (05): : 1733 - +
  • [3] Response to subcutaneous C1-esterase-inhibitor (C1-INH[SC]) for the prevention of hereditary angioedema attacks: Exploratory findings from the COMPACT study
    Zuraw, B. L.
    Craig, T.
    Cicardi, M.
    Longhurst, H.
    Jacobs, I
    Feuersenger, H.
    Dalton, S. R.
    Pragst, I
    ALLERGY, 2018, 73 : 163 - 164
  • [4] Subcutaneous C1-INH (SC) preparation (CSL830) in the prevention of Hereditary Angioedema (HAE) attacks: First findings from the COMPACT extension study
    Longhurst, H.
    Cicardi, M.
    Zuraw, B.
    Craig, T.
    Caballero, T.
    Farkas, H.
    Tarzi, M.
    Pragst, I
    Feuersenger, H.
    Jacobs, I
    ALLERGY, 2017, 72 : 100 - 101
  • [5] Onset of effect of prophylactic treatment with subcutaneous C1-esterase inhibitor (C1-INH [SC]) for prevention of Hereditary Angioedema (HAE) attacks: Findings from the phase III compact study
    Cicardi, M.
    Zuraw, B.
    Craig, T.
    Longhurst, H.
    Feuersenger, H.
    Jacobs, I
    Machnig, T.
    Pragst, I
    ALLERGY, 2018, 73 : 615 - 616
  • [6] INDIRECT COMPARISON BETWEEN HUMAN C1-INHIBITOR (C1-INH) SUBCUTANEOUS TREATMENT AND LANADELUMAB FOR ROUTINE PREVENTION OF HEREDITARY ANGIOEDEMA (HAE) ATTACKS
    Fridman, M.
    Supina, D.
    Lawo, J. P.
    VALUE IN HEALTH, 2020, 23 : S340 - S340
  • [7] Initiation of Prophylactic Treatment with Subcutaneous C1-Esterase Inhibitor (C1-INH [SC]) for Prevention of Hereditary Angioedema (HAE) Attacks and Onset of Effect: Findings from the Phase III COMPACT Study
    Li, Huamin Henry
    Riedl, Marc A.
    Craig, Timothy
    Longhurst, Hilary J.
    Cicardi, Marco
    Zuraw, Bruce L.
    Feuersenger, Henrike
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB45 - AB45
  • [8] Prevention of Hereditary Angioedema (HAE) attacks by anatomical location with subcutaneous C1-esterase inhibitor (C1-INH [SC]) treatment: Results from the phase III COMPACT study
    Craig, T.
    Zuraw, B.
    Cicardi, M.
    Longhurst, H.
    Chiao, J.
    Feuersenger, H.
    Jacobs, I
    Pragst, I
    ALLERGY, 2018, 73 : 615 - 615
  • [9] Subcutaneous C1-Esterase Inhibitor [C1-INH(SC)] to Prevent Hereditary Angioedema (HAE) Attacks: Subject and Investigator Assessments from the Compact Trial
    Longhurst, Hilary J.
    Li, Huamin Henry
    Riedl, Marc A.
    Craig, Timothy J.
    Reshef, Avner
    Farkas, Henriette
    Feuersenger, Henrike
    Wood, Daniel
    Watson, Douglas
    Pragst, Ingo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB234 - AB234
  • [10] Subcutaneous human C1-inhibitor (C1-INH) with recombinant human hyaluronidase (rHuPH20) for the prevention of angioedema attacks in patients with hereditary angioedema (HAE): health-related quality of life (HRQoL) results from a randomized, double-blind, dose-ranging, crossover study
    Weller, K.
    Maurer, M.
    Magerl, M.
    Fridman, M.
    Supina, D.
    Schranz, J.
    ALLERGY, 2015, 70 : 253 - 253
12345